Neogen Chemicals Ltd. Investor Presentation

06 Aug 2023

1319.40

0.27%

Investor Presentation

Neogen Chemicals Ltd - 542665 - Announcement under Regulation 30 (LODR)-Investor Presentation

BSE India

With reference to captioned subject, Please find enclosed herewith the Earnings Presentation on the Unaudited Financial Results (Standalone and Consolidated) of the Company for the Quarter ended June 30, 2023.

pdf

Neogen Chemicals Ltd.

14 May 2023

1319.40

0.27%

Investor Presentation

Neogen Chemicals Ltd - 542665 - Announcement under Regulation 30 (LODR)-Investor Presentation

BSE India

With reference to the captioned subject, please find enclosed herewith the Earnings Presentation on the Audited Financial Results (Standalone and Consolidated) of the Company for the quarter and year ended March 31, 2023. The Audited Financial Results for the quarter and year ended March 31, 2023 and the Earnings Presentation are also being uploaded on the Company's website at https://neogenchem.com/financial-performance/

pdf

Neogen Chemicals Ltd.

10 Apr 2023

1319.40

0.27%

Investor Presentation

Neogen Chemicals Ltd - 542665 - Announcement under Regulation 30 (LODR)-Investor Presentation

BSE India

With reference to the captioned subject, please find enclosed herewith the Presentation with respect to signing of a landmark agreement with MU Ionic Solutions Corporation, Japan to acquire manufacturing technology license for electrolytes in India.

pdf

Neogen Chemicals Ltd.

08 Mar 2023

1319.40

0.27%

Investor Presentation

Neogen Chemicals Ltd - 542665 - Announcement under Regulation 30 (LODR)-Investor Presentation

BSE India

With reference to the captioned subject, please find enclosed herewith the Earnings Presentation on Acquisition of 100% stake in BuLi Chemicals India Private Limited.

pdf

Neogen Chemicals Ltd.

12 Feb 2023

1319.40

0.27%

Investor Presentation

Neogen Chemicals Ltd - 542665 - Announcement under Regulation 30 (LODR)-Investor Presentation

BSE India

With reference to the captioned subject, please find enclosed herewith the Earnings Presentation on the Unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter and nine months ended December 31, 2022.

pdf